Cohance Lifesciences Gears Up for Q3 Reveal on 12th February; Check Key Expectations Here
Click and Sign Up to Get Live Updates on Q3 Results
Updated: 11 Feb 2026 • 3:10 pm
Posted by:
Cohance Lifesciences 's Q3 results FY26 are scheduled to be announced on 12th February 2026. Financial analysts anticipate an increase in revenue due to higher sales and a significant rise in PAT.
Cohance Lifesciences Q3 Results 2026 Preview
- Cohance Lifesciences' revenue is expected to be in the range of ₹307.15 crore, a 49.13% YoY decrease.
- Profit After Tax, or PAT, is projected to fall 40.15% YoY.
- Net profit is ₹82.88 crore, a fall 40.15% YoY
- EBITDA to fall 41.91%
Cohance Lifesciences Share Performance
- Over the past six months, Cohance Lifesciences' share price has fallen by 62.56% to ₹352.50.
- Moreover, over the past year, the stock has decreased by 67.01%.
- Despite this weak short-term performance, Cohance Lifesciences' stock has delivered a financially sound 67.61% return over the past 5 years.
- As of 11th February 2026, the stock traded at ₹352.60 per share.
Key Factors to Watch for Cohance Lifesciences Q3 Results FY26
- Revenue & Segment Growth: Trends in overall sales and performance across CDMO and API+ businesses.
- Profitability & Margins: EBITDA and net profit margins amid cost and operating pressures.
- Order Execution & Project Timing: Impact of timing of CDMO project starts and shipments.
- Niche Technology Demand: Growth in specialized chemistries like ADCs and oligonucleotides.
- Management Outlook: Guidance on FY26 growth trajectory and long-term goals.
Final Thoughts
Cohance Lifesciences will announce its Q3 FY26 results on 12th February 2026. Analysts expect % revenue growth, a 27.3% fall in PAT, and a 18.14% rise in EBITDA. Cohance Lifesciences focuses on revenue growth, margins, order execution, high-value segment performance, and management outlook.
Disclaimer: Investment in the share market is subject to risk. This news article is for informational purposes only. Conduct your own research before investing in shares and other securities.
Download the Univest iOS App or Univest Android App to get daily stock recommendations and insightful research pieces!
Recent Articles
GOCL Corporation Q3 Results FY26 Preview
Godrej Industries Q3 Results FY26 Preview
Godawari Power and Ispat Q3 Results FY26 Preview
Himatsingka Seide Q3 Results FY26 Preview
Igarashi Motors India FY26 Preview
Recent Articles
Gold Price Today, 30 October 2026: MCX Gold Falls 1.25% to Rs 1,40,808 Per 10 Grams and Spot Gold Slips Below $4,000, a 3.5-Month Low, as December Fed Hike Bets Build Ahead of Dhanteras
30 October 2026
Anthropic IPO Valuation: Aswath Damodaran Values the Claude Maker at $1.475 Trillion, Just Below the Reported $1.5 to $2 Trillion IPO Range, With Scenarios From Negative $373 Billion to $4.04 Trillion
30 October 2026
Equitas Small Finance Bank Share Price Crashes 10% to Rs 51.25 on 30 October 2026, Down 21% in Two Days After CEO PN Vasudevan Resigns Despite Record Equitas Q2 Results: What Is Going On?
30 October 2026
Greaves Cotton Share Price Jumps 10% Despite 81% Fall in Q2 Profit: What Is Driving the Rally?
30 October 2026
Note: This blog is for information purpose only. Investments and trading are subject to market risks, read all scheme related documents carefully.
Reviews
Recent Posts
Gold Price Today, 30 October 2026: MCX Gold Falls 1.25% to Rs 1,40,808 Per 10 Grams and Spot Gold Slips Below $4,000, a 3.5-Month Low, as December Fed Hike Bets Build Ahead of Dhanteras
Anthropic IPO Valuation: Aswath Damodaran Values the Claude Maker at $1.475 Trillion, Just Below the Reported $1.5 to $2 Trillion IPO Range, With Scenarios From Negative $373 Billion to $4.04 Trillion
Equitas Small Finance Bank Share Price Crashes 10% to Rs 51.25 on 30 October 2026, Down 21% in Two Days After CEO PN Vasudevan Resigns Despite Record Equitas Q2 Results: What Is Going On?
Greaves Cotton Share Price Jumps 10% Despite 81% Fall in Q2 Profit: What Is Driving the Rally?
Asian Paints Share Price After Q2 Results: Profit Up 7%, but Price Hikes Are Yet to Brighten Margins
Popular this week
Borosil Share Price Jumps 16% After Strong Q2 Results: Record Profit, Margin Jump and Key Price Levels to Know
Uniresearch Global Pvt Ltd
Research Analyst
SEBI Registration Number — INH000013776
Uniresearch is a subsidiary of Univest Communication Technologies Private Limited
Company Address: Registered Address: Ground Floor, Unitech Commercial Tower 2, Block B, Greenwood City, Unit 1-3, Sector 45, Gurugram, Haryana 122003
Write to us : support@univest.in, compliance@univest.in
Verify on SEBI registry →RESEARCH ANALYST
Get SEBI Registered
advice on the stocks
trending today.
Get 3 FREE Trade Ideas
for Startups Accelerator 2024
Trusted by 1Cr Indians
Awarded No.1 by Economic Times